{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T16:29:10Z","timestamp":1650990550146},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/1752-1947-9-29","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:51:26Z","timestamp":1434613886000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extended varenicline treatment in a severe cardiopathic cigarette smoker: a case report"],"prefix":"10.1186","volume":"9","author":[{"given":"Elena","family":"Munarini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Marabelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Boffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"key":"3157_CR1","volume-title":"The World Health Report","author":"The World Health Report","year":"2008","unstructured":"The World Health Report: The World Health Report. 2008. . Accessed 08 Jul 2014 \n                    http:\/\/www.who.int\/whr\/2008\/en\/"},{"issue":"5","key":"3157_CR2","first-page":"S3","volume":"8","author":"WB Kannel","year":"1990","unstructured":"Kannel WB, Higgins M: Smoking and hypertension as predictors of cardiovascular risk in population studies.J Hypertens 1990,8(5):S3\u20138.","journal-title":"J Hypertens"},{"issue":"4","key":"3157_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMsa1211128","volume":"368","author":"P Jha","year":"2013","unstructured":"Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al.: 21st-century hazards of smoking and benefits of cessation in the United States.N Engl J Med 2013,368(4):341\u201350. 10.1056\/NEJMsa1211128","journal-title":"N Engl J Med"},{"key":"3157_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.amepre.2008.04.009","volume":"35","author":"Clinical practice guideline treating tobacco use and dependence 2008 update panel, liaisons, and staff","year":"2008","unstructured":"Clinical practice guideline treating tobacco use and dependence 2008 update panel, liaisons, and staff: A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public health service report.Am J Prev Med 2008, 35:158\u201376.","journal-title":"Am J Prev Med"},{"key":"3157_CR5","first-page":"CD006103","volume":"4","author":"K Cahill","year":"2012","unstructured":"Cahill K, Stead LF, Lancaster T: Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev 2012, 4:CD006103. doi:10.1022\/14651858.CD006103","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3157_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.296.1.47","volume":"296","author":"D Gonzales","year":"2006","unstructured":"Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al.: Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.JAMA 2006,296(1):47\u201355. 10.1001\/jama.296.1.47","journal-title":"JAMA"},{"issue":"1","key":"3157_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.296.1.56","volume":"296","author":"DE Jorenby","year":"2006","unstructured":"Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al.: Varenicline phase 3 study group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.JAMA 2006,296(1):56\u201363. 10.1001\/jama.296.1.56","journal-title":"JAMA"},{"key":"3157_CR8","unstructured":"U.S. Food and Drug Administration: FDA approves novel medication for smoking cessation. Press release, 11 May 2006"},{"key":"3157_CR9","volume-title":"Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease","author":"FDA Drug Safety Communication","year":"2011","unstructured":"FDA Drug Safety Communication: Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease. 2011. . Accessed 08 Jul 2014 \n                    http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm259161.htm"},{"issue":"12","key":"3157_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1503\/cmaj.110218","volume":"183","author":"S Singh","year":"2011","unstructured":"Singh S, Loke YK, Spangler JG, Furberg CD: Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.CMAJ 2011,183(12):1359\u201366. 10.1503\/cmaj.110218","journal-title":"CMAJ"},{"key":"3157_CR11","doi-asserted-by":"publisher","first-page":"e2856","DOI":"10.1136\/bmj.e2856","volume":"344","author":"JJ Prochaska","year":"2012","unstructured":"Prochaska JJ, Hilton JF: Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.BMJ 2012, 344:e2856. 10.1136\/bmj.e2856","journal-title":"BMJ"},{"issue":"5","key":"3157_CR12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/030089161309900503","volume":"99","author":"E Munarini","year":"2013","unstructured":"Munarini E, Marabelli C, Marmotti A, Gardiner A, Invernizzi G, Mazza R, et al.: Antismoking centers in Milan\u2019s communal pharmacies: analysis of the 2010\u20132011 campaign.Tumori 2013,99(5):578\u201382.","journal-title":"Tumori"},{"issue":"2\u20133","key":"3157_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.drugalcdep.2009.09.011","volume":"107","author":"DS Courvoisier","year":"2010","unstructured":"Courvoisier DS, Etter JF: Comparing the predictive validity of five cigarette dependence questionnaires.Drug Alcohol Depend 2010,107(2\u20133):128\u201333.","journal-title":"Drug Alcohol Depend"},{"key":"3157_CR14","first-page":"455","volume":"40","author":"C Demaria","year":"1989","unstructured":"Demaria C, Grimaldi B, Lagrue G: Valeur pr\u00e9dictive des test psychologiques dans le sevrage tabagique.Semaine Des Hopitaux 1989, 40:455.","journal-title":"Semaine Des Hopitaux"},{"key":"3157_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1378\/chest.117.3.758","volume":"117","author":"ET Middleton","year":"2000","unstructured":"Middleton ET, Morice AH: Breath carbon monoxide as an indication of smoking habit.Chest 2000, 117:758\u201363. 10.1378\/chest.117.3.758","journal-title":"Chest"},{"key":"3157_CR16","unstructured":"Benowitz N: Basic and Clinical Pharmacology of Varenicline, CA Tobacco-Related Disease Research Program. Retrieved 3 March 2013. 17 Jen 2015 \n                    http:\/\/trdrp.org\/files\/varenicline\/benowitz-slides.pdf"},{"issue":"11","key":"3157_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4103\/0019-5359.58884","volume":"63","author":"DS Prasad","year":"2009","unstructured":"Prasad DS, Kabir Z, Dash AK, Das BC: Smoking and cardiovascular health: a review of the epidemiology, pathogenesis, prevention and control of tobacco.Indian J Med Sci 2009,63(11):520\u201333. 10.4103\/0019-5359.58884","journal-title":"Indian J Med Sci"},{"issue":"1","key":"3157_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jash.2012.11.003","volume":"7","author":"DM Sobieraj","year":"2013","unstructured":"Sobieraj DM, White WB, Baker WL: Cardiovascular effects of pharmacologic therapies for smoking cessation.J Am Soc Hypertens 2013,7(1):61\u20137. 10.1016\/j.jash.2012.11.003","journal-title":"J Am Soc Hypertens"},{"issue":"5","key":"3157_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/HCO.0b013e32833cd4f7","volume":"25","author":"V Aboyans","year":"2010","unstructured":"Aboyans V, Thomas D, Lacroix P: The cardiologist and smoking cessation.Curr Opin Cardiol 2010,25(5):469\u201377.","journal-title":"Curr Opin Cardiol"},{"key":"3157_CR20","unstructured":"FDA Drug Safety Communication: Safety review update of Chantix (varenicline) and risk of cardiovascular adverse events. . 12\/12\/2012. Accessed 01 Dec 2014 \n                    http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm330367.htm"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-9-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-9-29\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-9-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T11:35:43Z","timestamp":1548156943000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-9-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["3157"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-9-29","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]},"assertion":[{"value":"5 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}